Literature DB >> 19610050

Evaluation of photo-crosslinked fibrinogen as a rapid and strong tissue adhesive.

C M Elvin1, S J Danon, A G Brownlee, J F White, M Hickey, N E Liyou, G A Edwards, J A M Ramshaw, J A Werkmeister.   

Abstract

Tissue adhesives and sealants are commonly used in surgery either as an adjunct to, or replacement for, sutures. Previously, we have shown that fibrinogen can be crosslinked rapidly to give a high-strength bond in the presence of a ruthenium(II) complex, a persulfate and irradiation with visible light, and that the crosslinked fibrinogen is nontoxic to cells in vitro. This approach addresses limitations to current fibrin sealants that typically have relatively slow curing times and low bond strengths. In the present study, we have evaluated the efficacy and safety of this new biological scaffold sealant in various animal models. When placed as solid implants into rats, the crosslinked fibrinogen persisted for at least 8 weeks but was fully resorbed by 18 weeks with minimal inflammatory responses. When used as a tissue adhesive for repair of skin incisions in rats or as an arterial haemostat in pig, the photo-crosslinked fibrinogen sealed tissue or arrested bleeding within 20 s of application. For the skin incisions, the fibrinogen sealant promoted rapid tissue vascularization and cellular infiltration with no adverse foreign body cell generation. New collagen deposition occurred and with time the matrix had remodelled to acquire large mature collagen fiber bundles which were accompanied by maximum regenerated tensile strength. This biomaterial system may find useful applications in surgical procedures where rapid curing and/or high strength tissue sealing is required. Copyright 2009 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19610050     DOI: 10.1002/jbm.a.32572

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  8 in total

Review 1.  Fibrin-based biomaterials: modulation of macroscopic properties through rational design at the molecular level.

Authors:  Ashley C Brown; Thomas H Barker
Journal:  Acta Biomater       Date:  2013-09-19       Impact factor: 8.947

2.  Ruthenium-catalyzed photo cross-linking of fibrin-based engineered tissue.

Authors:  Jason W Bjork; Sandra L Johnson; Robert T Tranquillo
Journal:  Biomaterials       Date:  2010-12-31       Impact factor: 12.479

Review 3.  Elastic sealants for surgical applications.

Authors:  Nasim Annabi; Kan Yue; Ali Tamayol; Ali Khademhosseini
Journal:  Eur J Pharm Biopharm       Date:  2015-06-12       Impact factor: 5.571

Review 4.  Recent advances in 3D printing: vascular network for tissue and organ regeneration.

Authors:  Sung Yun Hann; Haitao Cui; Timothy Esworthy; Shida Miao; Xuan Zhou; Se-Jun Lee; John P Fisher; Lijie Grace Zhang
Journal:  Transl Res       Date:  2019-04-05       Impact factor: 7.012

5.  Evaluation of in situ curable biodegradable polyurethanes containing zwitterion components.

Authors:  Raju Adhikari; Stephen J Danon; Penny Bean; Tam Le; Pathiraja Gunatillake; John A M Ramshaw; Jerome A Werkmeister
Journal:  J Mater Sci Mater Med       Date:  2009-12-10       Impact factor: 3.896

Review 6.  Hemostatic strategies for traumatic and surgical bleeding.

Authors:  Adam M Behrens; Michael J Sikorski; Peter Kofinas
Journal:  J Biomed Mater Res A       Date:  2013-12-12       Impact factor: 4.396

7.  Matrix crosslinking enhances macrophage adhesion, migration, and inflammatory activation.

Authors:  Jessica Y Hsieh; Mark T Keating; Tim D Smith; Vijaykumar S Meli; Elliot L Botvinick; Wendy F Liu
Journal:  APL Bioeng       Date:  2019-03-27

8.  One-Step Photoactivation of a Dual-Functionalized Bioink as Cell Carrier and Cartilage-Binding Glue for Chondral Regeneration.

Authors:  Khoon S Lim; Florencia Abinzano; Paulina Nuñez Bernal; Ane Albillos Sanchez; Pau Atienza-Roca; Iris A Otto; Quentin C Peiffer; Michiya Matsusaki; Tim B F Woodfield; Jos Malda; Riccardo Levato
Journal:  Adv Healthc Mater       Date:  2020-04-23       Impact factor: 9.933

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.